ABBV vs DGX
By Alex · Tickerpine
AbbVie Inc. vs Quest Diagnostics Incorporated, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | DGX |
|---|---|---|
| Price | $295.03 | $259.60 |
| Market cap | $521.50B | $28.56B |
| P/E ratio | 50.7 | 25.9 |
| ROE | — | 15.32% |
| Profit margin | 15.67% | 9.54% |
| Revenue growth | 10.30% | 10.00% |
| Dividend yield | 2.35% | 1.33% |
| Beta | 0.19 | 0.55 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs DGX in plain English
- ABBV is the bigger company — about 18.3× the market cap of DGX.
- DGX is cheaper on earnings (P/E 25.9 vs 50.7).
- ABBV is growing revenue faster (10% vs 10%).
- ABBV has the higher dividend yield (2.35% vs 1.33%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
DGX return calculator
See what $1,000 in Quest Diagnostics Incorporated would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.